Periodontitis and cardiovascular diseases: Consensus report

Mariano Sanz1, Alvaro Marco Del Castillo2, Søren Jepsen3

  • 1Department of Dental Clinical Specialties, ETEP Research Group, Faculty of Odontology, University Complutense of Madrid, Madrid, Spain.

Insights

Severe periodontitis is linked to cardiovascular disease (CVD), a leading cause of death in Europe. This review updates evidence on this association and provides clinical recommendations for managing patients with both conditions.

Area of Science:

  • Periodontology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) causes 45% of deaths in Europe, with ischaemic heart disease and stroke as primary drivers.
  • Periodontitis, a prevalent chronic disease, affects 11.2% of the global population, with severe forms being the sixth most common human disease.
  • Existing evidence suggests independent associations between severe periodontitis and non-communicable diseases (NCDs), particularly CVD.

Purpose of the Study:

  • To update epidemiological evidence on the association between periodontitis and CVD.
  • To review mechanistic links between periodontitis and CVD.
  • To assess the impact of periodontal therapy on cardiovascular outcomes and patient management.

Main Methods:

  • A joint workshop by the European Federation of Periodontology (EFP) and World Heart Federation (WHF) reviewed recent scientific literature.
  • The review synthesized epidemiological data, mechanistic insights, and clinical trial findings.
  • Consideration was given to risks associated with periodontal therapy in patients on antithrombotic medication.

Main Results:

  • Significant associations between periodontitis and CVD are supported by updated epidemiological evidence.
  • Mechanistic pathways linking periodontitis and CVD have been further elucidated.
  • The impact of periodontal therapy on cardiovascular and surrogate outcomes has been evaluated.

Conclusions:

  • Periodontal therapy can influence cardiovascular and surrogate outcomes.
  • Recommendations are provided for dentists, physicians, and patients regarding the management of periodontitis and CVD.
  • Potential risks and complications of periodontal therapy in patients on antithrombotic therapy are addressed.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
706
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
800
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
374
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
187
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
540
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
293